Special use results survey for interstitial lung disease of ENHERTU FOR INTRAVENOUS DRIP INFUSION 100mg-gastric cancer
Not Applicable
- Conditions
- unresectable advanced / recurrent gastric cancer
- Registration Number
- JPRN-jRCT2001200001
- Lead Sponsor
- Matsuoka Yomei
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 900
Inclusion Criteria
All patients with unresectable advanced / recurrent gastric cancer who start administration of this drug within the enrollment period
Exclusion Criteria
NONE
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ILD expression based on the judgement result of ILD outside judgment Committee
- Secondary Outcome Measures
Name Time Method